The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and allied consumer products. Highnoon is a public limited company and its share are quoted on the Pakistan Stock Exchange (HINOON: PSX).
Highnoon announced the annual profits for the year ended Dec, 2018. The annual earnings of the company surged by 20% to Rs. 25.59. This has happened primarily due to the increased sales and other income of the company.
EPS: Rs. 25.59
Gross Profit: Rs. 3.54 Bn
Sales: Rs. 7.50 Bn
Profit After Taxation: Rs. 732 Mn